BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11711242)

  • 1. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure.
    Eyler FD; Behnke M; Garvan CW; Woods NS; Wobie K; Conlon M
    Neurotoxicol Teratol; 2001; 23(5):399-411. PubMed ID: 11711242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):237-41. PubMed ID: 9445497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine exposure and developmental outcome from birth to 6 months.
    Behnke M; Eyler FD; Garvan CW; Wobie K; Hou W
    Neurotoxicol Teratol; 2002; 24(3):283-95. PubMed ID: 12009484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance.
    Tronick EZ; Frank DA; Cabral H; Mirochnick M; Zuckerman B
    Pediatrics; 1996 Jul; 98(1):76-83. PubMed ID: 8668416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for congenital malformations in newborns with fetal cocaine exposure.
    Behnke M; Eyler FD; Garvan CW; Wobie K
    Pediatrics; 2001 May; 107(5):E74. PubMed ID: 11331724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief report: frequency of maternal cocaine use during pregnancy and infant neurobehavioral outcome.
    Schuler ME; Nair P
    J Pediatr Psychol; 1999 Dec; 24(6):511-4. PubMed ID: 10608102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.
    Lester BM; Tronick EZ; LaGasse L; Seifer R; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Lu J; Finnegan LP; Maza PL
    Pediatrics; 2002 Dec; 110(6):1182-92. PubMed ID: 12456917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal influence of prenatal cocaine exposure on child language functioning.
    Bandstra ES; Morrow CE; Vogel AL; Fifer RC; Ofir AY; Dausa AT; Xue L; Anthony JC
    Neurotoxicol Teratol; 2002; 24(3):297-308. PubMed ID: 12009485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prenatal cocaine/crack and other drug exposure on electroencephalographic sleep studies at birth and one year.
    Scher MS; Richardson GA; Day NL
    Pediatrics; 2000 Jan; 105(1 Pt 1):39-48. PubMed ID: 10617702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of in utero substance exposure on infant neurobehavior.
    Napiorkowski B; Lester BM; Freier MC; Brunner S; Dietz L; Nadra A; Oh W
    Pediatrics; 1996 Jul; 98(1):71-5. PubMed ID: 8668415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prenatal cocaine exposure on full-term infant neurobehavioral functioning.
    Morrow CE; Bandstra ES; Anthony JC; Ofir AY; Xue L; Reyes ML
    Neurotoxicol Teratol; 2001; 23(6):533-44. PubMed ID: 11792523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cocaine/polydrug exposure and maternal psychological distress on infant birth outcomes.
    Singer LT; Salvator A; Arendt R; Minnes S; Farkas K; Kliegman R
    Neurotoxicol Teratol; 2002; 24(2):127-35. PubMed ID: 11943500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive outcomes of preschool children with prenatal cocaine exposure.
    Singer LT; Minnes S; Short E; Arendt R; Farkas K; Lewis B; Klein N; Russ S; Min MO; Kirchner HL
    JAMA; 2004 May; 291(20):2448-56. PubMed ID: 15161895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample.
    Richardson GA; Hamel SC; Goldschmidt L; Day NL
    Pediatrics; 1999 Aug; 104(2):e18. PubMed ID: 10429136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic manifestations of in utero cocaine exposure in near-term and term infants.
    King TA; Perlman JM; Laptook AR; Rollins N; Jackson G; Little B
    Pediatrics; 1995 Aug; 96(2 Pt 1):259-64. PubMed ID: 7630680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative ability of biologic specimens and interviews to detect prenatal cocaine use.
    Eyler FD; Behnke M; Wobie K; Garvan CW; Tebbett I
    Neurotoxicol Teratol; 2005; 27(4):677-87. PubMed ID: 15922559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure.
    Bandstra ES; Morrow CE; Anthony JC; Accornero VH; Fried PA
    Neurotoxicol Teratol; 2001; 23(6):545-59. PubMed ID: 11792524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior.
    Chiriboga CA; Kuhn L; Wasserman GA
    Neurotoxicol Teratol; 2007; 29(3):323-30. PubMed ID: 17234383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing language skills of cocaine-exposed infants.
    Singer LT; Arendt R; Minnes S; Salvator A; Siegel AC; Lewis BA
    Pediatrics; 2001 May; 107(5):1057-64. PubMed ID: 11331686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.